PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-0.55%
Negative net income growth while ZETA stands at 40.68%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
12.76%
Some D&A expansion while ZETA is negative at -1.61%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
9.96%
Lower deferred tax growth vs. ZETA's 53.19%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
9.39%
SBC growth well above ZETA's 10.68%. Michael Burry would flag major dilution risk vs. competitor’s approach.
130.56%
Working capital change of 130.56% while ZETA is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
200.07%
AR growth while ZETA is negative at -367.30%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-67.13%
Negative yoy inventory while ZETA is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-139.11%
Negative yoy AP while ZETA is 224.45%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-154.75%
Negative yoy usage while ZETA is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
57.67%
Some yoy increase while ZETA is negative at -192.80%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
19.61%
Operating cash flow growth similar to ZETA's 20.83%. Walter Schloss would see parallel improvements or market conditions in cash generation.
9.50%
CapEx growth well above ZETA's 14.14%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
43.55%
Some acquisitions while ZETA is negative at -26.79%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
39.62%
Purchases growth of 39.62% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-40.10%
We reduce yoy sales while ZETA is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
11275.00%
We have some outflow growth while ZETA is negative at -39.54%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-10.60%
Both yoy lines negative, with ZETA at -18.84%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
41.18%
Issuance growth of 41.18% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-58.51%
Both yoy lines negative, with ZETA at -23.83%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.